Shantou Institute of Ultrasonic Instrument
301602
Hubei Sinophorus Electronic Materials
688545
Pansoft
300996
Jiayu Holding
300117
Wuxi Taclink Optoelectronics Technology
688205
CN Stock MarketDetailed Quotes
600436 Zhangzhou Pientzehuang Pharmaceutical
- 203.60
- -2.14-1.04%
Not Open Jan 22 15:00 CST
122.84BMarket Cap39.89P/E (TTM)
205.75High203.11Low14.71KlotVolume205.75Open205.74Pre Close299.75MTurnover0.24%Turnover Ratio43.91P/E (Static)603.32MShares283.1952wk High8.76P/B122.84BFloat Cap177.2252wk Low226.31Limit Up603.32MShs Float485.95Historical High185.17Limit Down1.28%Amplitude-7.33Historical Low3.47Dividend TTM203.74Avg Price8.37KlotAsk1.70%Div YieldTTM100Lot Size5.42KlotBid
Zhangzhou Pientzehuang Pharmaceutical Stock Forum
Sign in to post a comment
Semiconductor: $Semiconductor Manufacturing International Corporation (688981.SH)$ $NAURA Technology Group (002371.SZ)$
Securities: $CITIC (600030.SH)$ $East Money Information (300059.SZ)$
Insurance: $China Life Insurance (601628.SH)$ $Ping An Insurance (601318.SH)$
Auto Parts: $Fuyao Glass Industry Group (600660.SH)$ $Weichai Power (000338.SZ)$ $Ningbo Tuopu Group (601689.SH)$
Cars: $BYD Company Limited (002594.SZ)$
Software: $Beijing Kingsoft Office Software, Inc (688111.SH)$ $Hithink RoyalFlush Information Network (300033.SZ)$ $Iflytek Co.,ltd. (002230.SZ)$
...
Securities: $CITIC (600030.SH)$ $East Money Information (300059.SZ)$
Insurance: $China Life Insurance (601628.SH)$ $Ping An Insurance (601318.SH)$
Auto Parts: $Fuyao Glass Industry Group (600660.SH)$ $Weichai Power (000338.SZ)$ $Ningbo Tuopu Group (601689.SH)$
Cars: $BYD Company Limited (002594.SZ)$
Software: $Beijing Kingsoft Office Software, Inc (688111.SH)$ $Hithink RoyalFlush Information Network (300033.SZ)$ $Iflytek Co.,ltd. (002230.SZ)$
...
16
1
9
Despite a recent drop, Zhangzhou Pientzehuang Pharmaceutical's long-term returns remain impressive. The market sentiment remains steady, reflecting the EPS growth. The current sell-off could be an opportunity if sustainable growth continues.
Zhangzhou Pientzehuang Pharmaceutical's performance is commendable, with efficient reinvestment of its earnings leading to impressive earnings growth. The company's earnings growth is expected to continue at a similar rate, according to analyst forecasts.
Zhangzhou Pientzehuang Pharmaceutical investors remain upbeat despite high P/E ratio. However, comfort is wavering due to the difficulty of justifying these prices long-term without substantial growth rate improvements.
Zhangzhou Pientzehuang Pharmaceutical's share price reflects steady EPS growth indicating investor sentiment continuity. It appears that shareholders are rewarded generously via dividends, as suggested by total shareholder returns exceeding share price return.
No comment yet
102884128 : getting disappointed with this counter. every day drop.